In many parts of the US, cannabis is available for medical use under state law. Prescribers, manufacturers and distributors – not to mention patients – are all concerned about the safety and quality of cannabis for medical use. States have adopted different approaches to oversight, but the lack of consistency may leave patients at risk.
As part of the safety net that protects and promotes public health in the US, USP is taking steps to prevent harm to patients resulting from exposure to substandard, super-potent, contaminated or adulterated cannabis for medical use under state law.
USP is working with researchers, manufacturers, distributors, regulators and health care practitioners to protect public health and promote sound research by establishing a framework for the consistent characterization of cannabis for medical use.
